CytoReason
Trending Articles
Related Content
Research & Development
Cytoreason and Pfizer to use machine learning model of the immune system for drug discovery
CytoReason, a leader in machine learning for drug discovery and development, has entered into a collaboration agreement with Pfizer that will leverage CytoReason’s cell-centred models of the immune system